Identification of SRSF1 binding site regulating BIM splicing and its role in leukemia drug response
BCL-2-Interacting Mediator of Cell Death (BIM) is a pro-apoptotic BH3-only protein that plays an important role in regulating apoptosis. Hence, its deregulation is often observed in cancer as well as drug resistance. Alternative splicing give rise to different BIM transcripts, which translates into...
Saved in:
Main Author: | Tan, Cheryl Weiqi |
---|---|
Other Authors: | Francesco Paolo Cavallaro |
Format: | Final Year Project |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/72706 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
by: Liu, Jun, et al.
Published: (2018) -
Identification of cis-acting elements and splicing factors involved in the regulation of BIM pre-mRNA splicing
by: Juan, Wen Chun, et al.
Published: (2014) -
Identification of cis-acting elements and splicing factors involved in the regulation of BIM pre-mRNA splicing
by: Juan W.C., et al.
Published: (2018) -
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
by: Meggendorfer, M., et al.
Published: (2016) -
Characterization of trans-acting splicing factors that regulate BIM exon 3 splicing
by: Loh, Yan Ping
Published: (2016)